Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.813 USD | -2.37% | +8.35% | -72.11% |
03-15 | North American Morning Briefing : Inflation -2- | DJ |
03-14 | Top Midday Decliners | MT |
Sales 2024 * | 4.6M 6.3M | Sales 2025 * | 1.3M 1.78M | Capitalization | 34.27M 46.86M |
---|---|---|---|---|---|
Net income 2024 * | -49M -67.01M | Net income 2025 * | -60M -82.05M | EV / Sales 2024 * | -2.14 x |
Net cash position 2024 * | 44.1M 60.31M | Net cash position 2025 * | 89.5M 122M | EV / Sales 2025 * | -42.5 x |
P/E ratio 2024 * |
-0.71
x | P/E ratio 2025 * |
-0.83
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.37% |
Latest transcript on Spruce Biosciences, Inc.
1 day | -2.37% | ||
1 week | +8.35% | ||
Current month | +15.42% | ||
1 month | +15.80% | ||
3 months | -81.92% | ||
6 months | -24.33% | ||
Current year | -72.11% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22-01-02 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 20-04-30 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-09-08 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 16-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.8172 | -1.86% | 358 191 |
24-05-10 | 0.8327 | -0.68% | 243,215 |
24-05-09 | 0.8384 | -0.84% | 740,123 |
24-05-08 | 0.8455 | +5.75% | 735,242 |
24-05-07 | 0.7995 | +6.01% | 660,685 |
Delayed Quote Nasdaq, May 13, 2024 at 01:56 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.11% | 34.27M | |
+26.37% | 44.96B | |
-0.56% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.85% | 26.08B | |
-21.12% | 19.03B | |
+5.99% | 12.75B | |
+28.62% | 12.06B | |
-3.19% | 11.75B |
- Stock Market
- Equities
- SPRB Stock